Gastrointestinal bleeding in high risk survivors of myocardial infarction: the VALIANT Trial
Article 2009 en
Authors
GM
George V. Moukarbel
JS
James Signorovitch
MP
Michael Pfeffer
Abstract
1 min read
Following MI, clinical characteristics can identify patients with increased risk of GI bleeding. The use of dual antiplatelet agents appears to be the most profound risk factor. Whether these patients would benefit from GI prophylaxis therapy remains unknown.
Hironori Hara, Kuniaki Takahashi, Norihiro Kogame, Mariusz Tomaniak, Laura S.M. Kerkmeijer, Masafumi Ono, Hideyuki Kawashima, Rutao Wang, Chao Gao, Joanna J. Wykrzykowska, Robbert J. de Winter, Franz‐Josef Neumann, Sylvain Planté, Pedro A. Lemos, Scot Garg, Peter Jüni, Pascal Vranckx, Stephan Windecker, Marco Valgimigli, Christian W. Hamm, Philippe Gabríel Steg, Yoshinobu Onuma, Patrick W. Serruys
Alan Barkun, Majid A. Almadi, Ernst J. Kuipers, Loren Laine, Joseph J.�Y. Sung, Frances Tse, Grigorios I. Leontiadis, Neena S. Abraham, Xavier Calvet, Francis K.L. Chan, James D. Douketis, Robert Enns, Ian M. Gralnek, Vipul Jairath, Dennis M. Jensen, James Lau, Professor Gregory Lip, Romaric Loffroy, Fauze Maluf‐Filho, Andrew C. Meltzer, D. Nageshwar Reddy, John R. Saltzman, John K. Marshall,
Kent R. Nilsson, Sana M. Al‐Khatib, Yi Zhou, Karen S. Pieper, H. D. White, Aldo Maggioni, Lars Køber, Christopher B Granger, E. F. Lewis, John J.V. McMurray, Robert M. Califf, E. J. Velazquez
Kuniaki Takahashi, Ply Chichareon, Chun Chin Chang, Mariusz Tomaniak, Rodrigo Modolo, Norihiro Kogame, H P Stoll, Christian W. Hamm, Philippe Gabríel Steg, Yoshinobu Onuma, Marco Valgimigli, P Vranckx, Stephan Windecker, Didier Carrié, Patrick W. Serruys
Discussion(0)
No comments yet. Be the first to comment.